N/A N=384 Role of Membrane Sweeping on Initiation of Labor and Vaginal Birth in Previous Cesarean Section
Vaginal Birth After Cesarean Section
Primary: Number of Participants With Onset of Labor by 40 Weeks — 119; 90 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=2,804 The Twin Birth Study: A Trial Comparing Planned Vaginal Birth to Elective Caesarean Section of Twins
Twin Pregnancy
Primary: Perinatal/Neonatal Mortality and/or Serious Neonatal Morbidity — 60; 52; 24; 17 Participants
N/A N=1,485 Effect of a Patient-Centered Decision App on TOLAC
Pregnancy · Repeat Cesarean Section · Vaginal Births After Cesarean
Primary: Number of Participants Who Underwent a Trial of Labor After Cesarean (TOLAC) Delivery — 315; 338 Participants
N/A N=50 Physical Activity After a Normal Spontaneous or Cesarean Delivery
Postpartum Disorder
Primary: Steps — 968; 1771; 1652; 3165 Steps — p=0.002
N/A N=136 PROphylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese Population
Wound Complication
Primary: Number of Participants With Wound Complications — 3; 4 Participants
N/A N=149 Family-Centered Cesarean Delivery
Patient Satisfaction · Earlier Family Bond Initiation · Maternal and Neonatal Outcomes
Primary: 11-item Patient Satisfaction Questionnaire — 4.6; 4.4; 4.6; 4.3 units on a scale
N/A N=541 Cesarean Section Via Enhanced Recovery
Cesarean Section
Primary: Opioid Consumption — 60.34; 104.33 oral morphine equivalents (mg) — p=< 0.001
N/A N=226 Barbed Suture for Hysterotomy Closure During Cesarean Section
Hysterotomy
Primary: Quantitative Blood Loss — 641.8; 596.5 mL
N/A N=78 Randomized Control Trial of Second Stage of Labor
Labor Complications
Primary: Number of Patients Delivered by Cesarean — 16; 8 Participants
Phase 2 N=118 Enhanced Recovery at Cesarean Birth to Improve Postoperative Outcomes and Reduce Postoperative Length of Stay
Cesarean Section
Primary: Discharge on Postoperative Day #2 — 5; 2 Participants
N/A N=110 Negative Pressure Wound Therapy After Cesarean Delivery
Major Puerperal Infection, Postpartum · Wound Complications · Wound Seroma
Primary: Wound Complication Rate — 3; 1; 3; 6 participants
N/A N=70 Impact of Skin to Skin Contact on Maternal Satisfaction, Pain Scores, and Narcotic Usage After Cesarean Delivery
Skin to Skin Contact in Cesarean Deliveries
Primary: Maternal Evoked Pain Scores — 43.55 units on a scale
Phase 4 N=228 Epidural Morphine Following Vaginal Delivery
Pain
Primary: The Number of Women Who Received Systemic Narcotic Analgesics in the First 24 Hours Postpartum — 8; 37 participants — p=0.05
Phase 4 N=20 The Invia Motion at Cesarean Study
Negative Pressure Wound Therapy · Cesarean Section; Infection
Primary: Pain Scores: Discharge Time Frame — 2.5 score on a scale
N/A N=79 Improving Cesarean Section Experience Through Hypnotherapy
Cesarean Section · Pain · Anxiety
Primary: Wellbeing Measured Using a Comfort Scale — 6.7; 8.0 units on a scale
Phase 4 N=123 Buccal Misoprostol During Cesarean Section for Preventing Postpartum Hemorrhage
Postpartum Hemorrhage
Primary: Need for Additional Uterotonic Medications — 10; 40 percentage of participants — p=<0.01
N/A N=66 Vaginal Electrical Stimulation for Postpartum Neuromuscular Recovery
Obstetric Anal Sphincter Injury · Vaginal Electrical Stimulation
Primary: Anal Incontinence — 12; 4 Scores on a scale — p=0.04
N/A N=106 Accuracy of Blood Loss Estimation After Vaginal Delivery
Postpartum Hemorrhage
Primary: Difference in Actual Blood Volume and Estimated Blood Volume in Milliliters. — -20.8; -41.7; -53.5; -96.0 milliliters — p=<0.05
N/A N=80 Transversus Abdominis Plane Block Versus Wound Infiltration for Postcesarean Analgesia
Postcesarean Analgesia
Primary: Cumulative Fentanyl Dose — 157.4; 153.3 mcg
N/A N=368 Evaluation of Trials of Labor After Previous Cesarean Section in Ain Shams University Maternity Hospital
Vaginal Birth After Cesarean
Primary: Number of Participants With Successful Vaginal Birth — 317 Participants
N/A N=68 Optimal Management of Vasa Previa Study - A Retrospective Study
Vasa Previa
Primary: Diagnostic Profile of Techniques Utilized to Screen for and Diagnose Vasa Previa During Pregnancy. — 47; 13; 4; 2 Participants
N/A N=168 Short Term Comparison of Two Different Techniques of Uterine Cesarean Incision Closure
Cesarean Section Complications
Primary: Cesarean Scar Defect in the Uterine Incisional Line — 12; 39 participants — p=0.0001
N/A N=92 The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions
Post-operative Complications · Surgical Site Infection · Surgical Wound Infection
Primary: Incidence of Postoperative Surgical Site Occurrences (SSOs) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery. — 7; 2 participants
N/A N=96 Scalpel vs Diathermy in Repeat Cesarean Delivery
Complications; Cesarean Section
Primary: Incision Time . — 271.5; 188.17 Seconds — p=<0.001
N/A N=746 Cesarean Trial of Staples vs. Sutures
Cesarean Section · Wound Complications · Patient Satisfaction
Primary: Number of Participants With Wound Complications — 18; 40; 9; 14 Participants
Phase 2 N=100 The Effect of Tranexamic Acid on Postpartum Hemorrhage During and After Cesarean Delivery
Hemorrhage
Primary: The Amount of Hemorrhage During Cesarean Delivery and Within 2 Hours Afterward — 260; 380 ml
Phase 4 N=59 Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function
Vaginal Atrophy
Primary: Vulvar Assessment Scale (VUAS) — 0.10; 0.20 score on a scale
Phase 2 N=130 Enemas Before Elective Cesarean Section
Complications After Cesarean Section
Primary: Number of Participants With Bowel Sounds — 23; 31 participants — p=0.15
N/A N=441 Negative Pressure Wound Therapy in Cesarean Section
Postoperative Wound Complications
Primary: Number of Participants With Wound Complication — 37; 42 Participants — p=0.54
N/A N=168 Long Term Comparison of Two Different Techniques of Uterine Cesarean Incision Closure
Cesarean Section; Complications · Placenta Previa · Placenta Accreta
Primary: Placenta Previa — 18; 17; 0; 3 Participants